Munshi N, Ganju R K, Avraham S, Mesri E A, Groopman J E
Division of Experimental Medicine, Robert Mapplethorpe Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Biol Chem. 1999 Nov 5;274(45):31863-7. doi: 10.1074/jbc.274.45.31863.
The Kaposi's sarcoma-associated herpesvirus (KSHV) (also known as human herpesvirus 8) has been implicated in the pathogenesis of Kaposi's sarcoma and B cell primary effusion lymphomas. KSHV encodes a G protein-coupled receptor (GPCR) that acts as an oncogene and constitutively activates two protein kinases, c-Jun amino-terminal kinase (JNK)/stress-activated protein kinase (SAPK) and p38 mitogen-activated protein kinase. It also induces the production of vascular endothelial growth factor. These processes are believed to be important in KSHV-GPCR-related oncogenesis. We have characterized the signaling pathways mediated by KSHV-GPCR in a reconstituted 293T cell model in which the related adhesion focal tyrosine kinase (RAFTK) was ectopically expressed. RAFTK has been shown to play an important role in growth factor signaling in endothelium and in B cell antigen receptor signaling in B lymphocytes. KSHV-GPCR induced the tyrosine phosphorylation of RAFTK. Expression of wild-type RAFTK enhanced GPCR-mediated JNK/SAPK activation, whereas dominant-negative mutant constructs of RAFTK, such as K457A (which lacks kinase activity) and Y402F (a Src-binding mutant), inhibited KSHV-GPCR-mediated activation of JNK/SAPK. RAFTK also mediated the KSHV-GPCR-induced activation of Lyn, a Src family kinase. However, RAFTK did not mediate the activation of p38 mitogen-activated protein kinase induced by KSHV-GPCR. Human interferon gamma-inducible protein-10, which is known to inhibit KSHV-GPCR activity, was found to reduce RAFTK phosphorylation and JNK/SAPK activation. These results suggest that in cells expressing RAFTK/proline-rich tyrosine kinase 2, such as endothelial and B cells, RAFTK can act to enhance KSHV-GPCR-mediated downstream signaling to transcriptional regulators such as JNK/SAPK.
卡波西肉瘤相关疱疹病毒(KSHV)(也称为人类疱疹病毒8型)与卡波西肉瘤和B细胞原发性渗出性淋巴瘤的发病机制有关。KSHV编码一种G蛋白偶联受体(GPCR),该受体作为一种癌基因,持续激活两种蛋白激酶,即c-Jun氨基末端激酶(JNK)/应激激活蛋白激酶(SAPK)和p38丝裂原活化蛋白激酶。它还诱导血管内皮生长因子的产生。这些过程被认为在与KSHV-GPCR相关的肿瘤发生中很重要。我们在重组的293T细胞模型中对KSHV-GPCR介导的信号通路进行了表征,在该模型中异位表达了相关粘附灶酪氨酸激酶(RAFTK)。RAFTK已被证明在内皮细胞的生长因子信号传导以及B淋巴细胞的B细胞抗原受体信号传导中起重要作用。KSHV-GPCR诱导了RAFTK的酪氨酸磷酸化。野生型RAFTK的表达增强了GPCR介导的JNK/SAPK激活,而RAFTK的显性负性突变体构建体,如K457A(缺乏激酶活性)和Y402F(一种Src结合突变体),则抑制了KSHV-GPCR介导的JNK/SAPK激活。RAFTK还介导了KSHV-GPCR诱导的Src家族激酶Lyn的激活。然而,RAFTK并未介导KSHV-GPCR诱导的p38丝裂原活化蛋白激酶的激活。已知可抑制KSHV-GPCR活性的人干扰素γ诱导蛋白10被发现可降低RAFTK磷酸化和JNK/SAPK激活。这些结果表明,在表达RAFTK/富含脯氨酸的酪氨酸激酶2的细胞中,如内皮细胞和B细胞,RAFTK可以增强KSHV-GPCR介导的下游信号传导至转录调节因子,如JNK/SAPK。